Galapagos NV GLPG

$ 34.61 0.61%

Annual report 2024
added 01-24-2026

Galapagos NV DIO Ratio 2011-2026 | GLPG

Annual DIO Ratio Galapagos NV

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	0.915	0.923	2.2	1.55	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
2.2	0.915	1.4

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	GlaxoSmithKline plc GSK	200	$ 48.98	0.68 %	$ 173 B	Britain
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Grifols, S.A. GRFS	0.000171	$ 9.25	1.49 %	$ 6.83 B	Spain
	Amphastar Pharmaceuticals AMPH	132	$ 25.92	-0.86 %	$ 1.26 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Ultragenyx Pharmaceutical RARE	1.25 K	$ 24.45	4.49 %	$ 2.21 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	BioXcel Therapeutics BTAI	227	$ 1.84	1.66 %	$ 4.66 M	USA
	Aytu BioScience AYTU	209	$ 2.66	-1.85 %	$ 16.7 M	USA
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Coherus BioSciences CHRS	116	$ 2.04	28.3 %	$ 192 M	USA
	Biogen BIIB	394	$ 171.89	-1.1 %	$ 25 B	USA